| |
|
|
| Name: |
Sands Capital Ventures LLC |
| City: |
ARLINGTON |
| State: |
VA |
| Zip: |
22209 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
10 |
|
View All Holdings |
Currently
Viewing:
Unchanged Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
TXG |
10x Genomics, Inc. |
6 |
- |
$0.00 |
$26,960,000 |
481,770 |
7.5% |
7,087,000 |
0 |
0.526 |
N/A |
|
|
ABOS |
Acumen Pharmaceuticals, Inc. |
7 |
- |
$0.00 |
$13,122,000 |
3,417,075 |
3.65% |
-1,059,000 |
0 |
8.443 |
N/A |
|
|
ACRV |
Acrivon Therapeutics, Inc. |
9 |
- |
$8.48 |
$8,131,000 |
1,652,605 |
2.26% |
-7,668,000 |
0 |
7.915 |
N/A |
|
|
TARS |
Tarsus Pharmaceuticals, Inc. |
10 |
- |
$0.00 |
$5,265,000 |
260,000 |
1.46% |
645,000 |
0 |
0.975 |
N/A |
|
|
MASS |
908 Devices Inc. |
11 |
- |
$6.56 |
$2,662,000 |
237,258 |
0.74% |
1,082,000 |
0 |
0.914 |
N/A |
|
|
SPRB |
Spruce Biosciences, Inc. |
12 |
- |
$0.00 |
$2,306,000 |
787,007 |
0.64% |
527,000 |
0 |
2.107 |
N/A |
|
|
TSHA |
Taysha Gene Therapies, Inc. |
13 |
- |
$0.00 |
$1,283,000 |
724,873 |
0.36% |
-1,008,000 |
0 |
1.96 |
N/A |
|
|
CADL |
Candel Therapeutics, Inc. |
14 |
- |
$0.00 |
$1,193,000 |
811,737 |
0.33% |
446,000 |
0 |
2.829 |
N/A |
|
|
ABSI |
Absci Corp |
15 |
- |
$5.06 |
$243,000 |
57,804 |
0.07% |
167,000 |
0 |
0.063 |
N/A |
|
|
GTLB |
Gitlab Inc. |
21 |
- |
$53.27 |
$41,000 |
658 |
0.01% |
11,000 |
0 |
0.001 |
N/A |
|
